ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,291.68
0.36%
Dow Jones
44,736.57
0.99%
Gold vs US Dollar
2,622.39
0.50%
Brent Oil
72.675
0.10%
Bitcoin
94,650.14
1.68%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Endonovo Therapeutics Inc (PK) (ENDV)

  7. Endonovo Therapeutics Inc (PK) (ENDV) News

Endonovo Therapeutics (PK) (ENDV)

Endonovo Therapeutics Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ENDV
DateTimeSourceHeadlineSymbolCompany
19/09/202419:00Edgar (US Regulatory)Form SEC STAFF ACTION - SEC Staff Action: ORDERUSOTC:ENDVEndonovo Therapeutics Inc (PK)
02/02/202422:23Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:ENDVEndonovo Therapeutics Inc (PK)
03/01/202422:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ENDVEndonovo Therapeutics Inc (PK)
29/12/202320:20Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]USOTC:ENDVEndonovo Therapeutics Inc (PK)
04/12/202314:08Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ENDVEndonovo Therapeutics Inc (PK)
15/11/202317:21Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ENDVEndonovo Therapeutics Inc (PK)
12/10/202310:03Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ENDVEndonovo Therapeutics Inc (PK)
25/08/202311:04Edgar (US Regulatory)Form 1-A/A - Offering Statement [Regulation A]: [Amend]USOTC:ENDVEndonovo Therapeutics Inc (PK)
21/08/202321:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ENDVEndonovo Therapeutics Inc (PK)
14/06/202318:27Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:ENDVEndonovo Therapeutics Inc (PK)
16/05/202310:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
17/04/202320:39Edgar (US Regulatory)Annual Report (10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
31/03/202319:55Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
29/03/202311:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
14/11/202214:27Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
27/09/202217:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
22/08/202213:14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
15/08/202213:46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
16/05/202213:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
10/05/202222:36Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:ENDVEndonovo Therapeutics Inc (PK)
31/03/202220:18Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
19/11/202114:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
15/11/202115:12Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
23/08/202119:06Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
16/08/202114:11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
24/05/202120:13Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
17/05/202120:45Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
13/04/202121:17Edgar (US Regulatory)Annual Report (10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
31/03/202121:01Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
19/11/202021:57Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:ENDV

Your Recent History

LSE
SCLP
Scancell
LSE
GPM
Golden Prospect Precious...
LSE
EMG
Man
LSE
NFDS
Northern Foods
LSE
OCDO
Ocado
LSE
QED
Quadrise
LSE
GDR
Genedrive
LSE
GSF
Gore Street Energy Storage
LSE
KGF
Kingfisher
LSE
SRSP
Sirius Petroleum
LSE
TRC
The Revel Collective
LSE
SMIN
Smiths
LSE
VAST
Vast Resources
LSE
GKP
Gulf Keystone Petroleum
LSE
XPS
Xps Pensions
LSE
VOF
Vinacapital Vietnam Oppo...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Silver

    1 year 40%, 2 years 50% and *3 years 60%

    *Across 3 years £903.96 only 361.58